RE:Q3 ResultsLittleGuy2 wrote: As we await Q3 results and the hype builds on this forum with all its usual hyperbole, I just want to put it out there that my hope is for modest revenue. Not the multi-million $ bonanza predicted by many SH pundits, but modest, stable revenue built on good operating practices. Without quality accessioning, accurate reporting, no contaminated flume hoods (think NFL), and excellence in customer service, Stage will lose ground in any attempts to succeed as a cancer company. Customers will come for the Covid but not stay for the cancer if the service is not top notch.
So I am hoping at this stage the company is paying attention to the quality dial & not the bank account. I am assuming the institutional investors are likewise steering the Stage board in that direction.
No need to worry about Quaility good sir.....in the Q2 Presentation, Mr Tripp made a point literally the very first paragraph after the forward looking statements.....
"I think as we focus on company overview, Its important to remember first and foremost that we are a cancer testing company. This is what we do. As a result of that everything we do has to be extremily accurate, everything has to be extremly well done, it has to be very timely. This is how we approarch everything, including the Covid Testing, remeber too, that evrything is focused around Aristotle" https://www.webcaster4.com/Player/Index?webcastId=36633&g=ee1c8cbb-69e4-4cc3-8a3a-304098741711&uid=5328840&sid=